TFRC and viral infectious disease: Other novel therapies such as antibody blockade of NW arenavirus receptor human transferrin receptor 1 (hTFR1), which is the receptor used by all the pathogenic clade B NW arenaviruses, has recently shown promise in preventing viral infection with the potential for cross protection [46].